increased solubility = different PK profile? [Dissolution / BCS / IVIVC]

posted by nobody – 2017-06-08 19:16 (2805 d 11:34 ago) – Posting: # 17462
Views: 14,902

Hi Dr!

To me: That's not how it works with generics. Go for equivalent dissolution and therefore Cmax/AUC. End of story.

Why go for "better" solubility and end up non-BE? ;-) Don't see the point at all.

You could go for some hybrid application in Europe (regulatory is not my piece of cake), but good luck with explaining the "advantage" of your product to the authority(ies) :-D

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,662 registered users;
26 visitors (0 registered, 26 guests [including 4 identified bots]).
Forum time: 05:51 CET (Europe/Vienna)

Skill is a function of chance.
It’s an intuitive best-use of chance situations.    Philip K. Dick

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5